Pma/510(k)#: p100022 and s001.This complaint is reportable to the fda on the basis of the reporting precedence established for this product family for stent fracture, regardless of the patient outcome.This complaint is related to 1 x ziv6-35-125-7.0-60-ptx device of lot number c774345.The ziv6-35-125-7.0-60-ptx of lot number c774345 was implanted in the patient therefore is not available for evaluation.With the information provided a document based investigation was carried out.Images were requested to support the complaint investigation, however it has been confirmed that no images will be provided.As no imaging was available, there is no evidence to suggest that stent fracture did not occur therefore this complaint is confirmed based on customer testimony.It can be noted that stent fracture type 1 (single strut fracture) was observed 3 years after stent implantation.It is possible that the stent fracture could have occurred due to patient¿s lifestyle; however this cannot be confirmed.Due to limited information and lack of imaging, the root cause of this complaint cannot be determined and no other comments can be made.According to package insert supplied with each zilver ptx device, stent strut fracture is noted as potential adverse event associated with the placement of this device.In addition, the following information is provided: ¿through clinical trial, it has been shown that stent fracture rates in (b)(6) patients may be higher than the rest of the world.The clinical significance is unknown since these fractured cases have not been associated with any clinical sequelae, however, take enough consideration into the lifestyle of the patient in (b)(6).¿ prior to distribution all zilver ptx devices are subject to visual inspection and functional checks to ensure device integrity.A review of the relevant manufacturing records revealed no discrepancies that could have contributed to this complaint.According to information provided no medical or surgical intervention was performed and no adverse effects to the patient have been reported.Quality engineering will continue to monitor complaints of this nature for potential emerging trends.
|